BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26360921)

  • 1. Hypothermia for preventing chemotherapy-induced neuropathy - a pilot study on safety and tolerability in healthy controls.
    Bandla A; Sundar R; Liao LD; Sze Hui Tan S; Lee SC; Thakor NV; Wilder-Smith EP
    Acta Oncol; 2016; 55(4):430-6. PubMed ID: 26360921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy.
    Bandla A; Tan S; Kumarakulasinghe NB; Huang Y; Ang S; Magarajah G; Hairom Z; Lim JSJ; Wong A; Chan G; Ngoi N; Ang E; Lee YM; Chan A; Lee SC; Thakor N; Wilder-Smith E; Sundar R
    Support Care Cancer; 2020 Aug; 28(8):3691-3699. PubMed ID: 31811482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limb Hypothermia for the Prevention of Chemotherapy-Induced Peripheral Neuropathy - Modality for Optimal Cooling.
    Bandla A; Santhanakrishnan P; Magarajah G; Vaidya GA; Subramanian A; Wei H; Wilder-Smith E; Chin LS; Thakor N; Sundar R
    Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():5061-5064. PubMed ID: 33019124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
    Bao T; Seidman AD; Piulson L; Vertosick E; Chen X; Vickers AJ; Blinder VS; Zhi WI; Li Q; Vahdat LT; Dickler MN; Robson ME; Mao JJ
    Eur J Cancer; 2018 Sep; 101():12-19. PubMed ID: 30007894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative Approach for the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Pilot Study With the Hilotherm Device, the Poliambulanza Hospital Experience.
    Oneda E; Meriggi F; Zanotti L; Zaina E; Bighè S; Andreis F; Rueda S; Zaniboni A
    Integr Cancer Ther; 2020; 19():1534735420943287. PubMed ID: 32856475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive hypothermia as a neuroprotective strategy for paclitaxel-induced peripheral neuropathy.
    Beh ST; Kuo YM; Chang WW; Wilder-Smith E; Tsao CH; Tsai CH; Chen LT; Liao LD
    Pain; 2019 Jul; 160(7):1505-1521. PubMed ID: 30839425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limb Hypothermia for Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Study.
    Sundar R; Bandla A; Tan SS; Liao LD; Kumarakulasinghe NB; Jeyasekharan AD; Ow SG; Ho J; Tan DS; Lim JS; Vijayan J; Therimadasamy AK; Hairom Z; Ang E; Ang S; Thakor NV; Lee SC; Wilder-Smith EP
    Front Oncol; 2016; 6():274. PubMed ID: 28119855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.
    Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M
    Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryotherapy for the prevention of chemotherapy-induced peripheral neuropathy: A systematic review.
    Bailey AG; Brown JN; Hammond JM
    J Oncol Pharm Pract; 2021 Jan; 27(1):156-164. PubMed ID: 32955997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer.
    Speck RM; Sammel MD; Farrar JT; Hennessy S; Mao JJ; Stineman MG; DeMichele A
    J Oncol Pract; 2013 Sep; 9(5):e234-40. PubMed ID: 23943894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN).
    Choi V; Park SB; Lacey J; Kumar S; Heller G; Grimison P
    BMJ Open; 2024 Jan; 14(1):e076391. PubMed ID: 38195173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced peripheral neuropathy: prevention and treatment.
    Pachman DR; Barton DL; Watson JC; Loprinzi CL
    Clin Pharmacol Ther; 2011 Sep; 90(3):377-87. PubMed ID: 21814197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy.
    Vollmers PL; Mundhenke C; Maass N; Bauerschlag D; Kratzenstein S; Röcken C; Schmidt T
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1785-1792. PubMed ID: 29943097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updating your peripheral neuropathy "know-how".
    Marrs J; Newton S
    Clin J Oncol Nurs; 2003; 7(3):299-303. PubMed ID: 12793336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
    Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
    BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of chemotherapy-induced peripheral neuropathy.
    Piccolo J; Kolesar JM
    Am J Health Syst Pharm; 2014 Jan; 71(1):19-25. PubMed ID: 24352178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathy.
    Han FY; Kuo A; Nicholson JR; Corradinni L; Smith MT
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1067-1075. PubMed ID: 29781509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis.
    Wu S; Bai X; Guo C; Huang Z; Ouyang H; Huang J; Zeng W
    BMC Cancer; 2021 Nov; 21(1):1173. PubMed ID: 34727879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.